A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

PHASE2CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Atopic DermatitisPlaque Psoriasis
Interventions
DRUG

PF-07038124 ointment 0.01%

Atopic Dermatitis and Plaque Psoriasis

DRUG

Vehicle ointment

Atopic Dermatitis and Plaque Psoriasis

DRUG

PF-07038124 ointment 0.03%

Atopic Dermatitis and Plaque Psoriasis

DRUG

PF-07038124 ointment 0.06%

PF-07038124 ointment 0.06% (Plaque Psoriasis only)

Trial Locations (39)

10028

Icahn School of Medicine at Mount Sinai, New York

10029

Icahn School of Medicine at Mount Sinai, New York

11042

Northwell Health Clinical Trials Office, Lake Success

23502

Virginia Clinical Research, Inc., Norfolk

31217

Skin Care Physicians of Georgia, Macon

32256

Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Jacksonville

33613

ForCare Clinical Research, Tampa

33991

Renaissance Research and Medical Group, Cape Coral

38119

Clinical Neuroscience Solutions Inc., Memphis

Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Memphis

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

48109

University of Michigan, Ann Arbor

48124

Wayne Health, Dearborn

57702

Health Concepts, Rapid City

61761

Sneeze, Wheeze & Itch Associates, LLC, Normal

70808

Velocity Clinical Research at The Dermatology Clinic, Baton Rouge, Baton Rouge

74136

Vital Prospects Clinical Research Institute, PC, Tulsa

75230

Dermatology Treatment and Research Center, Dallas

78213

Progressive Clinical Research, San Antonio

78218

Texas Dermatology and Laser Specialists, San Antonio

90033

USC/Norris Comprehensive Cancer Center, Los Angeles

92024

California Dermatology & Clinical Research Institute, Encinitas

97504

Velocity Clinical Research, Medford, Medford

T2J 7E1

Dermatology Research Institute, Calgary

R3M 3Z4

Wiseman Dermatology Research Inc., Winnipeg

L3P 1X3

Lynderm Research Inc., Markham

L4Y 4C5

DermEdge Research, Mississauga

L5H 1G9

DermEdge Research, Mississauga

K9J 5K2

SKiN Centre for Dermatology, Peterborough

H2X 2V1

Innovaderm Research Inc., Montreal

G1V 4X7

Centre de Recherche Dermatologique du Quebec metropolitain, Québec

080-0013

Takagi Dermatological Clinic Branch, Obihiro

Takagi Dermatology, Obihiro

657-0846

Dermatology Shimizu Clinic, Kobe

593-8324

Dermatology and Ophthalmology Kume Clinic, Sakai

933-0871

Shirasaki dermatology clinic, Takaoka

HP11 2QW

Egin Research High Wycombe, High Wycombe

SO16 6YD

Southampton General Hospital, Southampton

HA6 2RN

Accellacare - North London, Northwood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05375955 - A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis. | Biotech Hunter | Biotech Hunter